NCT01990053

Brief Summary

Standard treatments for depression in specialty care settings are effective but resources for delivering empirically supported psychotherapies are often limited. Computerized cognitive behavioral therapy (cCBT) is an effective and highly scalable treatment for depression that might help expand services in psychiatric settings, however, little is known about its efficacy in this population. The present study aims to establish the efficacy of a internet-delivered cCBT program ("Beating the Blues") plus email and telephone support for depression in a psychiatric outpatient clinic setting. The secondary aim is to pilot an assessment procedure designed to identify moderators of treatment effectiveness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P75+ for not_applicable major-depressive-disorder

Timeline
Completed

Started Apr 2014

Typical duration for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2013

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 21, 2013

Completed
5 months until next milestone

Study Start

First participant enrolled

April 14, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2016

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

March 24, 2023

Status Verified

March 1, 2023

Enrollment Period

2.1 years

First QC Date

October 28, 2013

Last Update Submit

March 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Hamilton Rating Scale for Depression (HRSD) from 0 to 8 weeks

    The 17-item HRSD, modified to assess atypical symptoms, is a standard interview-administered measure of depressive symptom severity. The HRSD will be administered by study personnel supervised by the Principal Investigator.

    week 0, week 8

Secondary Outcomes (1)

  • Change in Patient Health Questionnaire-9 (PHQ9) over 8 weeks

    weeks 0-8

Other Outcomes (2)

  • Change in Generalized Anxiety Disorder-7 (GAD7) over 8 weeks

    weeks 0-8

  • Change in Depression Anxiety and Stress Scale-21 (DASS21) over 8 weeks

    week 0, week 8

Study Arms (2)

Beating the Blues

EXPERIMENTAL

Beating the Blues plus helper support.

Behavioral: Beating the Blues

Waitlist Condition

NO INTERVENTION

Eight week waitlist condition group parallel to the immediate treatment condition with optional entrance into the Beating the Blues after the first eight weeks

Interventions

The BtB program guides patients through a series of 8 fully automated online lessons intended to help them identify and change problematic patterns of thinking and behavior that maintain depression. Support will be provided by licensed professional therapists over the phone or via email.

Also known as: Beating the Blues (BtB)
Beating the Blues

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Major Depressive Disorder (MDD) according to Diagnostic and Statistical Manual Fourth Edition criteria
  • Able and willing to give informed consent
  • Have access to a computer with an internet connection at home

You may not qualify if:

  • History of bipolar affective disorder or psychosis
  • Current Axis I disorder other than MDD if it constitutes the predominate aspect of the clinical presentation and if it requires treatment other than that being offered
  • History of substance dependence in the past six months
  • Subnormal intellectual potential (IQ below 80)
  • Clear indication of secondary gain (e.g., court ordered treatment or compensation issues)
  • Current suicide risk or significant intentional self-harm in the last six months sufficient to preclude treatment on an outpatient basis
  • Discharge within six moths from a higher level of care (inpatient, partial hospital, or intensive outpatient treatment)
  • Currently undergoing outpatient psychotherapy
  • Current antidepressant medication treatment if the individual has had a change in medication over the past month or is planning a change in medication during the duration of the study
  • Inability to read and write English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Daniel R Strunk, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 28, 2013

First Posted

November 21, 2013

Study Start

April 14, 2014

Primary Completion

May 3, 2016

Study Completion

May 1, 2017

Last Updated

March 24, 2023

Record last verified: 2023-03

Locations